The goal of this clinical trial is to evaluate the efficacy and safety of an electric stimulator for medical use by personal (LRTPM1) in patients with early to intermediate dry age-related macular degeneration.
The main questions this study aims to answer are:
* Does the investigational device improve visual function, as assessed by best corrected visual acuity and contrast sensitivity?
* What treatment-emergent adverse events occur during the study?
Participants will:
* Be randomized to receive either active stimulation or sham stimulation
* Apply the assigned investigational device at home once daily for 30 minutes over a 12-week treatment period
* Visit the study site for eye examinations and safety assessments
* Return for a follow-up visit 4 weeks after the end of treatment